Kidney involvement in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy in a Finnish cohort

Nephrology Dialysis Transplantation

Volumn 29, Issue 9, 2014, Pages 1750-1757

  Kluger, Nicolas ^a   Kataja, Janne ^b   Aho, Heikki ^c   Rönn, Ann Mari ^a   Krohn, Kai ^d   Ranki, Annamari ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b Department of Pediatrics Hospital District of South West Finland Turku ^*  (Finland)

^c HOSPITAL DISTRICT OF SOUTHWEST FINLAND   (Finland)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy; Chronic renal failure; Transplantation; Tubular renal acidosis; Tubulo interstitial nephritis

Indexed keywords

ALDOSTERONE; BETA 2 MICROGLOBULIN; CREATININE; CYCLOSPORIN; CYSTATIN C; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RENIN; RITUXIMAB; IMMUNOLOGIC FACTOR; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY; MYCOPHENOLATE MOFETIL; MYCOPHENOLIC ACID;

ACUTE KIDNEY TUBULE NECROSIS; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AIRE GENE; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; CHILD; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GENE; GENE EXPRESSION; GENE IDENTIFICATION; GENE MUTATION; GENETIC MARKER; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HUMAN; HYPERCALCEMIA; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL NEPHRITIS; KERATOCONJUNCTIVITIS; KIDNEY BIOPSY; KIDNEY CALCIFICATION; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; KIDNEY TUBULE ACIDOSIS; MALE; NEPHRON; PATIENT MONITORING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEINURIA; PYURIA; RETROSPECTIVE STUDY; ANALOGS AND DERIVATIVES; BLOOD; COMPLICATION; FINLAND; FLUORESCENT ANTIBODY TECHNIQUE; MIDDLE AGED; NEPHRITIS, INTERSTITIAL; PATHOPHYSIOLOGY; POLYENDOCRINOPATHY; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; CHILD; CREATININE; FEMALE; FINLAND; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOLOGIC FACTORS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; NEPHRITIS, INTERSTITIAL; POLYENDOCRINOPATHIES, AUTOIMMUNE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84907383101     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfu064     Document Type: Article

References (33)

1. Perheentupa J. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Clin Endocrinol Metab 2006; 91: 2843-2850
2. Kluger N, Ranki A, Krohn K. APECED: is this a model for failure of T cell and B cell tolerance? Front Immunol 2012; 3: 232
3. Arstila TP, Jarva H. Human APECED; a Sick Thymus Syndrome? Front Immunol 2013; 4: 313
4. Heino M, Peterson P, Kudoh J et al. Autoimmune regulator is expressed in the cells regulating immune tolerance in thymus medulla. Biochem Biophys Res Commun 1999; 257: 821-825
5. Kogawa K, Nagafuchi S, Katsuta H et al. Expression of AIRE gene in peripheral monocyte/dendritic cell lineage. Immunol Lett 2002; 80: 195-198.
6. Gardner JM, Metzger TC, McMahon EJ et al. Extrathymic Aire-expressing cells are a distinct bone marrow-derived population that induce functional inactivation of CD4+ T cells. Immunity 2013; 39: 560-572
7. Husebye ES, Perheentupa J, Rautemaa R et al. Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I. J Intern Med 2009; 265: 514-529
8. Söderbergh A, Myhre AG, Ekwall O et al. Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab 2004; 89: 557-562
9. Meager A, Visvalingam K, Peterson P et al. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1. PLoS Med 2006; 3: e289
10. Ahonen P, Myllärniemi S, Sipilä I et al. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med 1990; 322: 1829-1836
11. Zlotogora J, Shapiro MS. Polyglandular autoimmune syndrome type I among Iranian Jews. J Med Genet 1992; 29: 824-826
12. Betterle C, Greggio NA, Volpato M. Clinical review 93: autoimmune polyglandular syndrome type 1. J Clin Endocrinol Metab 1998; 83: 1049-1055
13. Wolff AS, Erichsen MM, Meager A et al. Autoimmune polyendocrine syndrome type 1 in Norway: phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene. J Clin Endocrinol Metab 2007; 92: 595-603
14. Orlova EM, Bukina AM, Kuznetsova ES et al. Autoimmune polyglandular syndrome type 1 in Russian patients: clinical variants and autoimmune regulator mutations. Horm Res Paediatr 2010; 73: 449-457
15. Podkrajsek KT, Milenković T, Odink RJ et al. Detection of a complete autoimmune regulator gene deletion and two additional novel mutations in a cohort of patients with atypical phenotypic variants of autoimmune polyglandular syndrome type 1. Eur J Endocrinol 2008; 159: 633-639
16. Zaidi G, Sahu RP, Zhang L et al. Two novel AIRE mutations in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) among Indians. Clin Genet 2009; 76: 441-448
17. Mazza C, Buzi F, Ortolani F et al. Clinical heterogeneity and diagnostic delay of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome. Clin Immunol 2011; 139: 6-11
18. Proust-Lemoine E, Saugier-Véber P, Lefranc D et al. Autoimmune polyendocrine syndrome type 1 in north-western France: AIRE gene mutation specificities and severe forms needing immunosuppressive therapies. Horm Res Paediatr 2010; 74: 275-284
19. Meloni A, Willcox N, Meager A. Autoimmune Polyendocrine syndrome type 1: an extensive longitudinal study in Sardinian patients. J Clin Endocrinol Metab 2012; 97: 1114-1124
20. Hannigan NR, Jabs K, Perez-Atayde AR et al. Autoimmune interstitial nephritis and hepatitis in polyglandular autoimmune syndrome. Pediatr Nephrol 1996; 10: 511-514
21. Ulinski T, Perrin L, Morris M et al. Autoimmune polyendocrinopathy- candidiasis- ectodermal dystrophy syndrome with renal failure: impact of posttransplant immunosuppression on disease activity. J Clin Endocrinol Metab 2006; 91: 192-195
22. Al-Owain M, Kaya N, Al-Zaidan H et al. Renal failure associated with APECED and terminal 4q deletion: evidence of autoimmune nephropathy. Clin Dev Immunol 2010; 2010: 586342
23. Kluger N, Jokinen M, Krohn K et al. What is the burden of living with autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED) in 2012? A health-related quality-of-life assessment in Finnish patients. Clin Endocrinol (Oxf) 2013; 79: 134-141
24. Kluger N, Krohn K, Ranki A. Absence of some common organspecific and non-organ-specific autoimmunity in autoimmune polyendocrinopathy candidiasis ectodermal dystrophy. Endocr Connect 2013; 2: 61-68
25. Fetissov SO, Bensing S, Mulder J et al. Autoantibodies in autoimmune polyglandular syndrome type I patients react with major brain neurotransmitter systems. J Comp Neurol 2009; 513: 1-20
26. Jahnukainen T, Ala-Houhala M, Karikoski R et al. Clinical outcome and occurrence of uveitis in children with idiopathic tubulointerstitial nephritis. Pediatr Nephrol 2011; 26: 291-299
27. Merenmies L, Tarkkanen A. Chronic bilateral keratitis in autoimmune polyendocrinopathy-candidiadis-ectodermal dystrophy (APECED). A long-term follow-up and visual prognosis. Acta Ophthalmol Scand 2000; 78: 532-535
28. Braden GL, O'Shea H, Mulhern JG. Tubulointerstitial diseases. Am J Kidney Dis 2005; 46: 560-572
29. Boitard C. Pancreatic islet autoimmunity. Presse Med 2012; 41: e636-e650
30. Gaarder PI, Heier HE. A human autoantibody to renal collecting duct cells associated with thyroid and gastric autoimmunity and possibly renal tubular acidosis. Clin Exp Immunol 1983; 51: 29-37
31. Aukee S, Krohn K. Occurrence and progression of gastritis in patients operated on for peptic ulcer. Scand J Gastroenterol 1972; 7: 541-546
32. Finlayson ND, Jokelainen PT, Krohn K et al. Proceedings: virus-like particles and hepatitis B antigen (HBAg) in chronic hepatitis and cirrhosis. Gut 1973; 14: 821
33. Popler J, Alimohammadi M, Kämpe O et al. Autoimmune polyendocrine syndrome type 1: utility of KCNRG autoantibodies as a marker of active pulmonary disease and successful treatment with rituximab. Pediatr Pulmonol 2012; 47: 84-87